Hudson Bay Capital Management
DMIIR

Hudson Bay Capital Management’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Hudson Bay Capital Management’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$136K Sell
1,705,350
-263,680
-13% -$30K ﹤0.01% 1153
2025
Q4 		$276K Buy
+1,969,030
New +$281K ﹤0.01% 931

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Hudson Bay Capital Management's DMIIR Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 13% in Q1 2026, selling an estimated $30K and leaving 1,705,350 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Hudson Bay Capital Management first reported a position in DMIIR in Q4 2025 and has held it in 2 quarters since. The position peaked at $276K in Q4 2025. 57 funds tracked by Wall St. Rank hold DMIIR as of Q1 2026.

  • Hudson Bay Capital Management held 1,705,350 shares of Drugs Made In America Acquisition II Corp Right worth $136K as of Q1 2026.
  • Hudson Bay Capital Management sold 263,680 Drugs Made In America Acquisition II Corp Right shares in Q1 2026, an estimated $30K.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1153 holding.
  • Hudson Bay Capital Management first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 2 quarters since.
  • Hudson Bay Capital Management's Drugs Made In America Acquisition II Corp Right position peaked at $276K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.